It won't take you long to notice it: Health Decisions is not your traditional CRO.
Yes, we're a full-service clinical research organization, global in scope. We have 20 years of experience in all major therapeutic areas. Our clients are leading biotech and pharmaceutical companies worldwide. We've completed Phase I - IV trials, global registration studies and multiple 510(k)s and PMAs.
But it's not just what we do that makes us stand out - it's how much better we do it. Significantly accelerating study timelines. Reducing waste. Minimizing costs. Maximizing both the return on investment and net present value (NPV) for our sponsors' drug development projects. Optimizing their patent protection and long-term revenue by helping them market or fail their product faster.
We do it all without sacrificing quality or accuracy. And all because of a remarkably efficient, highly untraditional methodology called Agile.
How much better?
Our commitment to efficiency gets results that far exceed industry standards, time and again. By focusing on operational efficiencies, Health Decisions typically cuts 10 to 40% off traditional development cycles.
Health Decisions vs. Traditional Study Cycle
Want some hard numbers? Here are a few examples of what we've achieved in drug and device studies:
- Completed a mBrCa study 9 months ahead of schedule, increasing product sales by $366m according to The New York Times.
- Saved $32 million for the sponsor of a $110 million Alzheimer's study by completing the 5-year study in 3.5 years.
- Reduced a cardiovascular study timeline by 2/3 and restored the viability of a drug out-licensed for complexity.
- Shortened the timeline of an in-progress 4,000-person, 7-year device study by 3 months to meet early submission requirements.
Our results make a difference. To more than just our clients.
Results like these are delighting our sponsors and leading an industry change. With Agile Clinical Development, Health Decisions has become a force for reducing medical care costs and speeding the delivery of life-enhancing drugs.
We've also become the recipient of many prestigious awards. We're honored to be recognized by the following organizations for growth, excellence in technology and entrepreneurship:
- The Business Champions Awards
- CIO Enterprise Value Award
- Cisco Growing With Technology Award
- Inc 500 (fastest-growing private companies in the U.S.)
- Deloitte & Touche Technology Fast 500
- Ernst & Young Entrepreneur of the Year Award, Health Sciences
